WinstonWınston
Back
Stock

Radius Residential Care Limited

RAD.NZ
49
Medical - Care Facilities · Healthcare
Price
NZ$0.43
+0.01 (+1.18%)
Market Cap
NZ$121.9M
Exchange
New Zealand Exchange
Winston Score
49
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Sep 21, 2026 · filings through Mar 31, 2026

§How the score breaks down

Quality
Weak
Growth
Good
Cash Flow
Strong
Stability
Weak
Valuation
Strong
Dividends
Exceptional
Track this stock — start free trial

Share count rising — dilution

+19.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 237.6M (2022) → 283.9M (2026)

§Winston Score History

The full picture

Headquartered in Auckland, New Zealand, Radius Residential Care Limited has been a prominent provider of health and elder care services across the country since its establishment in 2003. The company focuses on supporting elderly and disabled individuals, delivering a comprehensive range of offerings including residential, hospital-level, dementia-specific, respite, and palliative care, as well as general rest home and private hospital services. Its extensive operations encompass 23 aged care facilities, collectively offering approximately 1,780 care beds, alongside three retirement villages that feature 101 independent living units. Additionally, Radius manages an e-commerce platform dedicated to specialized assisted living products.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+9.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-38.2% YoY

YoY Growth Rate

Earnings declining

R&D Spend

NZ$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Cash Position

Cash flow positive

NZ$83M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Radius Residential Care Limited is growing revenue at 10% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
8.9%
Thin — 8.9% gross margin
Profit after running costs
Operating Margin
8.9%
Modest — 8.9% operating margin
Return on the money invested
ROCE
7.1%
Weak — 7.1% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+12.8%
Fast-growing sales (+12.8% YoY)
Profit growth
EPS YoY
+34.8%
Earnings growing fast (+34.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
266%
Turns 266% of profit into real cash
Spare cash per sale
FCF Margin
5.4%
Thin free cash flow (5.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.80
Heavy debt load (2.80)
Covers its interest
Interest Cover
1.77x
Dangerous — barely covers interest (1.8x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
12.9x
Attractive valuation — P/E 12.9

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+2.0
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
4.65%
Healthy income — 4.65% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
+61.8%
Dividend growing fast (61.8% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial